Assets Zmiana Data
Abbott USD 73.35B 440M 2023-06
Acadia Pharmaceuticals USD 748.96M 116.42M 2023-12
Acorda Therapeutics USD 364.7M 10.21M 2023-06
Agios Pharmaceuticals USD 937.12M 70.14M 2023-12
Akebia Therapeutics USD 241.7M 6.7M 2023-12
Alnylam Pharmaceuticals USD 3.83B 9.19M 2023-12
AstraZeneca USD 96.09B 457M 2023-09
BioMarin Pharmaceutical USD 6.84B 83.44M 2023-12
Bluebird Bio USD 613.61M 49.78M 2023-09
Eli Lilly USD 57.92B 3.1B 2023-09
Esperion Therapeutics USD 221.3M 13.32M 2023-09
Halozyme Therapeutics USD 1.73B 159.39M 2023-12
Illumina USD 10.11B 11M 2023-12
Insmed USD 1.33B 4.96M 2023-12
Ironwood Pharmaceuticals USD 471.07M 52.99M 2023-12
J&J USD 166.06B 25.62B 2023-09
Lexicon Pharmaceuticals USD 276.48M 40.24M 2023-09
MannKind USD 475.2M 154.87M 2023-12
Merck USD 106.73B 2.26B 2023-09
Moderna USD 18.43B 1.02B 2023-12
PTC Therapeutics USD 1.9B 635.81M 2023-12
Regulus Therapeutics USD 37.75M 5.9M 2023-09
Sarepta Therapeutics USD 3.11B 16.18M 2023-09
Thermo Fisher Scientific USD 98.73B 1.67B 2023-12
Ultragenyx Pharmaceutical USD 1.49B 252.87M 2023-12
United Therapeutics USD 7.17B 143.4M 2023-12
Vanda Pharmaceuticals USD 641.68M 2.85M 2023-06



Lexicon Pharmaceuticals Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2024.